Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation.
Abnormally expanded polyglutamine domains in proteins are associated with several neurodegenerative diseases, of which the best known is Huntington's. Expansion of the polyglutamine domain facilitates aggregation of the affected protein, and several studies directly link aggregation to neurotoxicity. The age of onset of disease is inversely correlated with the length of the polyglutamine domain; this correlation motivates an examination of the role of the length of the domain on aggregation. In this investigation, peptides containing 8 to 24 glutamines were synthesized, and their conformational and aggregation properties were examined. All peptides lacked secondary structure. Fluorescence resonance energy transfer studies revealed that the peptides became increasingly collapsed as the number of glutamine residues increased. The effective persistence length was estimated to decrease from approximately 11 to approximately 7 A as the number of glutamines increased from 8 to 24. A comparison of our data with theoretical results suggests that phosphate-buffered saline is a good solvent for Q8 and Q12, a theta solvent for Q16, and a poor solvent for Q20 and Q24. By dynamic light scattering, we observed that Q16, Q20, and Q24, but not Q8 or Q12, immediately formed soluble aggregates upon dilution into phosphate-buffered saline at 37 degrees C. Thus, Q16 stands at the transition point between good and poor solvent and between stable and aggregation-prone peptide. Examination of aggregates by transmission electron microscopy, along with kinetic assays for sedimentation, provided evidence indicating that soluble aggregates mature into sedimentable aggregates. Together, the data support a mechanism of aggregation in which monomer collapse is accompanied by formation of soluble oligomers; these soluble species lack regular secondary structure but appear morphologically similar to the sedimentable aggregates into which they eventually mature.
Walters
Robert H
RH
Department of Chemical and Biological Engineering, University of Wisconsin, Madison, 1415 Engineering Drive, Madison, WI 53706, USA.
Murphy
Regina M
RM
D000595:Amino Acid Sequence; D002942:Circular Dichroism; D031541:Fluorescence Resonance Energy Transfer; D006801:Humans; D006816:Huntington Disease / Q000235:genetics / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000235:genetics; D017510:Protein Folding; D017433:Protein Structure, Secondary; D019680:Trinucleotide Repeat Expansion
D010455:Peptides; C097188:polyglutamine
Eur J Biochem. 2004 Aug;271(15):3155-70
15265035
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11884-9
12186976
Biochemistry. 2004 Mar 2;43(8):2141-54
14979710
J Mol Biol. 2001 Aug 3;311(1):173-82
11469866
FEBS Lett. 2002 Feb 27;513(2-3):267-72
11904162
Biochemistry. 1981 Dec 8;20(25):7206-11
6797470
J Mol Biol. 2007 Aug 3;371(1):235-44
17560603
Biochemistry. 2007 Nov 6;46(44):12810-20
17929830
Neuron. 2002 Aug 29;35(5):819-22
12372277
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16764-9
17075061
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R115-23
17911155
J Phys Chem B. 2008 Oct 23;112(42):13172-6
18817433
J Chem Phys. 2006 Mar 14;124(10):104905
16542102
Cell. 1997 Dec 12;91(6):753-63
9413985
J Pept Res. 1997 Jul;50(1):73-5
9273890
Biophys J. 1994 Sep;67(3):1238-46
7811938
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2754-9
15699337
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):892-7
15642944
J Neurochem. 2008 Feb;104(3):846-58
17986219
Biophys J. 2009 Feb 18;96(4):1515-28
19217868
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15400-5
16230628
Lancet. 2003 May 10;361(9369):1642-4
12747895
Nat Struct Mol Biol. 2007 Apr;14(4):332-40
17369839
Hum Mol Genet. 2008 Feb 1;17(3):345-56
17947294
Anal Biochem. 1994 Apr;218(1):1-13
8053542
Science. 1997 May 16;276(5315):1112-6
9148805
Science. 2002 Jun 21;296(5576):2149-50
12077389
J Phys Chem B. 2005 Mar 17;109(10):4788-95
16851563
Genes Dev. 2001 Apr 15;15(8):925-32
11316786
Nat Rev Neurosci. 2000 Nov;1(2):109-15
11252773
Biophys J. 2006 Jul 1;91(1):276-88
16617069
Biophys J. 2009 Apr 8;96(7):2871-87
19348769
Biochemistry. 2002 Jun 11;41(23):7391-9
12044172
J Biol Chem. 2007 Mar 23;282(12):9195-203
17170113
Proteins. 2007 Jan 1;66(1):96-109
17068817
Hum Mol Genet. 2002 Nov 1;11(23):2905-17
12393802
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12394-9
16894178
Proc Natl Acad Sci U S A. 1970 Apr;65(4):823-30
16591825
Biophys J. 2009 Jul 8;97(1):303-11
19580768
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12605-10
19549822
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14367-72
16980414
J Mol Biol. 2006 Feb 17;356(2):325-34
16375920
J Mol Biol. 2008 Dec 5;384(1):279-97
18824003
Protein Sci. 2001 Apr;10(4):887-91
11274480
Biol Chem. 2000 Sep-Oct;381(9-10):937-42
11076024
Trends Neurosci. 2008 Oct;31(10):521-8
18778858
Biophys J. 2004 Apr;86(4):2467-83
15041684
Prog Neurobiol. 2007 Nov;83(4):211-27
17240517